Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
13.67
-0.64 (-4.47%)
At close: Jul 25, 2025, 4:00 PM
13.87
+0.20 (1.46%)
After-hours: Jul 25, 2025, 7:48 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $1.99 billion as of July 25, 2025. Its market cap has decreased by -35.68% in one year.
Market Cap
1.99B
Enterprise Value
983.73M
1-Year Change
-35.68%
Ranking
Category
Stock Price
$13.67
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $1.99B, an increase of 5.23%. That is a compound annual growth rate of 0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 1.99B | -32.29% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.19B |
| Johnson & Johnson | 406.87B |
| AbbVie | 336.59B |
| Novo Nordisk | 309.02B |
| UnitedHealth Group | 265.35B |
| Novartis AG | 227.08B |
| AstraZeneca | 224.54B |
| Abbott Laboratories | 218.92B |